145 related articles for article (PubMed ID: 30590020)
1. Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX® and Quanterix SiMoA methodologies.
Poorbaugh J; Samanta T; Bright SW; Sissons SE; Chang CY; Oberoi P; MacDonald AJ; Martin AP; Cox KL; Benschop RJ
J Immunol Methods; 2019 Mar; 466():9-16. PubMed ID: 30590020
[TBL] [Abstract][Full Text] [Related]
2. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
[TBL] [Abstract][Full Text] [Related]
3. A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?
Casaletto KB; Elahi FM; Fitch R; Walters S; Fox E; Staffaroni AM; Bettcher BM; Zetterberg H; Karydas A; Rojas JC; Boxer AL; Kramer JH
Cytokine; 2018 Nov; 111():481-489. PubMed ID: 29908923
[TBL] [Abstract][Full Text] [Related]
4. Bioanalytical challenges in development of ultrasensitive Home Brew assays: a case study using IL-13.
Sperinde G; Hokom M; Peng K; Fischer SK
Bioanalysis; 2019 Jun; 11(11):1045-1054. PubMed ID: 31251105
[No Abstract] [Full Text] [Related]
5. Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assay.
Ulndreaj A; Sohaei D; Thebault S; Pons-Belda OD; Fernandez-Uriarte A; Campbell C; Cheo D; Stengelin M; Sigal G; Freedman MS; Scarisbrick IA; Prassas I; Diamandis EP
Diagnosis (Berl); 2023 Aug; 10(3):275-280. PubMed ID: 36788117
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum.
Yeung D; Ciotti S; Purushothama S; Gharakhani E; Kuesters G; Schlain B; Shen C; Donaldson D; Mikulskis A
J Immunol Methods; 2016 Oct; 437():53-63. PubMed ID: 27555238
[TBL] [Abstract][Full Text] [Related]
7. Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.
Bastarache JA; Koyama T; Wickersham NE; Ware LB
J Immunol Methods; 2014 Jun; 408():13-23. PubMed ID: 24768796
[TBL] [Abstract][Full Text] [Related]
8. Performance evaluation of three platforms with ultrasensitive ligand-binding assay potential.
Cowan KJ; Geiger A; Hornauer H; Rourick R; Siguenza PY
Bioanalysis; 2017 Jun; 9(12):937-946. PubMed ID: 28627218
[TBL] [Abstract][Full Text] [Related]
9. Immunochemistry for high-throughput screening of human exhaled breath condensate (EBC) media: implementation of automated Quanterix SIMOA instrumentation.
Pleil JD; Angrish MM; Madden MC
J Breath Res; 2015 Dec; 9(4):047108. PubMed ID: 26658359
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and binding kinetics of an ultra-sensitive chemiluminescent enzyme-linked immunosorbent assay at arrays of antibodies.
Tobos CI; Kim S; Rissin DM; Johnson JM; Douglas S; Yan S; Nie S; Rice B; Sung KJ; Sikes HD; Duffy DC
J Immunol Methods; 2019 Nov; 474():112643. PubMed ID: 31401067
[TBL] [Abstract][Full Text] [Related]
11. A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's Perspective.
Chunyk AG; Joyce A; Fischer SK; Dysinger M; Mikulskis A; Jeromin A; Lawrence-Henderson R; Baker D; Yeung D
AAPS J; 2017 Dec; 20(1):10. PubMed ID: 29196830
[TBL] [Abstract][Full Text] [Related]
12. Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer's disease.
Thijssen EH; Verberk IMW; Vanbrabant J; Koelewijn A; Heijst H; Scheltens P; van der Flier W; Vanderstichele H; Stoops E; Teunissen CE
Sci Rep; 2021 May; 11(1):9736. PubMed ID: 33958661
[TBL] [Abstract][Full Text] [Related]
13. Development of an ultra-sensitive Simoa assay to enable GDF11 detection: a comparison across bioanalytical platforms.
Myzithras M; Li H; Bigwarfe T; Waltz E; Gupta P; Low S; Hayes DB; MacDonnell S; Ahlberg J; Franti M; Roberts S
Bioanalysis; 2016 Mar; 8(6):511-8. PubMed ID: 26917343
[TBL] [Abstract][Full Text] [Related]
14. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis.
Malekzadeh A; Twaalfhoven H; Wijnstok NJ; Killestein J; Blankenstein MA; Teunissen CE
Cytokine; 2017 Mar; 91():145-152. PubMed ID: 28082233
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6.
Chaturvedi S; Siegel D; Wagner CL; Park J; van de Velde H; Vermeulen J; Fung MC; Reddy M; Hall B; Sasser K
Br J Clin Pharmacol; 2015 Oct; 80(4):687-97. PubMed ID: 25847183
[TBL] [Abstract][Full Text] [Related]
16. Development of a three-plex single molecule immunoassay enabling measurement of the EGFR ligands amphiregulin, betacellulin and transforming growth factor α simultaneously in human serum samples.
Olsen DA; Kjaer IM; Brandslund I
J Immunol Methods; 2018 Aug; 459():63-69. PubMed ID: 29803775
[TBL] [Abstract][Full Text] [Related]
17. An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65.
Costa OR; Verhaeghen K; Roels S; Stangé G; Ling Z; Pipeleers D; Gorus FK; Martens GA
PLoS One; 2018; 13(3):e0193670. PubMed ID: 29518118
[TBL] [Abstract][Full Text] [Related]
18. A fully-automated, six-plex single molecule immunoassay for measuring cytokines in blood.
Rivnak AJ; Rissin DM; Kan CW; Song L; Fishburn MW; Piech T; Campbell TG; DuPont DR; Gardel M; Sullivan S; Pink BA; Cabrera CG; Fournier DR; Duffy DC
J Immunol Methods; 2015 Sep; 424():20-7. PubMed ID: 25960176
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
[TBL] [Abstract][Full Text] [Related]
20. Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic.
Myzithras M; Lin S; Radden L; Hess Kenny C; Cai Z; MacDonald A; Binetti R; Marlow M; Fracasso P; Gibson G; Bartlett C; Hawkins J; Hansel S
MAbs; 2022; 14(1):2104153. PubMed ID: 35916739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
